nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—Gadobenate Dimeglumine—ALB—chronic obstructive pulmonary disease	0.0139	1	CrCbGaD
Gadopentetate dimeglumine—PGD—respiratory system—chronic obstructive pulmonary disease	0.0138	0.209	CbGeAlD
Gadopentetate dimeglumine—PGD—connective tissue—chronic obstructive pulmonary disease	0.0122	0.184	CbGeAlD
Gadopentetate dimeglumine—PGD—bronchus—chronic obstructive pulmonary disease	0.0114	0.172	CbGeAlD
Gadopentetate dimeglumine—PGD—smooth muscle tissue—chronic obstructive pulmonary disease	0.0111	0.169	CbGeAlD
Gadopentetate dimeglumine—PGD—trachea—chronic obstructive pulmonary disease	0.0102	0.155	CbGeAlD
Gadopentetate dimeglumine—PGD—lung—chronic obstructive pulmonary disease	0.00735	0.111	CbGeAlD
Gadopentetate dimeglumine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00168	0.00183	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00168	0.00183	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00183	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00175	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00175	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00175	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.0016	0.00174	CcSEcCtD
Gadopentetate dimeglumine—Cough—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00174	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00159	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00158	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00158	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00156	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00155	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00155	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.0015	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00161	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00161	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00148	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00145	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00152	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00139	0.00151	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00151	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00151	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00151	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00132	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Pain—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00129	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00129	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00138	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00138	CcSEcCtD
Gadopentetate dimeglumine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00134	CcSEcCtD
Gadopentetate dimeglumine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00134	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0012	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00119	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.0011	0.0012	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00104	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00112	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00111	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00111	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00101	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.0011	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000988	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000985	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00097	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00097	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000961	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000961	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000961	0.00104	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000961	0.00104	CcSEcCtD
Gadopentetate dimeglumine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000955	0.00104	CcSEcCtD
Gadopentetate dimeglumine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000955	0.00104	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000952	0.00103	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00095	0.00103	CcSEcCtD
Gadopentetate dimeglumine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000942	0.00102	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000941	0.00102	CcSEcCtD
Gadopentetate dimeglumine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000936	0.00102	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000928	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000925	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000922	0.001	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000915	0.000995	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000912	0.000992	CcSEcCtD
Gadopentetate dimeglumine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000908	0.000987	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000907	0.000986	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000907	0.000986	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000906	0.000985	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000906	0.000985	CcSEcCtD
Gadopentetate dimeglumine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000902	0.00098	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000889	0.000967	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000887	0.000964	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000877	0.000953	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000874	0.00095	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00086	0.000935	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000855	0.00093	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00083	0.000902	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000826	0.000898	CcSEcCtD
Gadopentetate dimeglumine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000812	0.000883	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000806	0.000876	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000798	0.000868	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000789	0.000858	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000784	0.000852	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000766	0.000833	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000763	0.000829	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000755	0.00082	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000742	0.000806	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00074	0.000804	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000735	0.000799	CcSEcCtD
Gadopentetate dimeglumine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000706	0.000768	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000681	0.00074	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000676	0.000735	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000672	0.00073	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000663	0.000721	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000659	0.000717	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000656	0.000713	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000646	0.000702	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000637	0.000693	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000635	0.00069	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000626	0.00068	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000624	0.000678	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000622	0.000676	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000608	0.000661	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.0006	0.000652	CcSEcCtD
Gadopentetate dimeglumine—Shock—Prednisone—chronic obstructive pulmonary disease	0.00059	0.000642	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000589	0.00064	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000586	0.000637	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000583	0.000634	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00058	0.000631	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000572	0.000622	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000547	0.000594	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000546	0.000594	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000539	0.000586	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000522	0.000567	CcSEcCtD
Gadopentetate dimeglumine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000521	0.000566	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00052	0.000565	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000517	0.000562	CcSEcCtD
Gadopentetate dimeglumine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000517	0.000562	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000513	0.000558	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000495	0.000538	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000491	0.000533	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000491	0.000533	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000477	0.000518	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000474	0.000516	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000474	0.000516	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000442	0.000481	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000431	0.000468	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000425	0.000462	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000411	0.000446	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000397	0.000431	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000382	0.000415	CcSEcCtD
Gadopentetate dimeglumine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000378	0.000411	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000378	0.000411	CcSEcCtD
Gadopentetate dimeglumine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000409	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000356	0.000387	CcSEcCtD
